오가피를 활용한 음료인 BS-01이 비만 생쥐의 체중 및 혈청 내 지질 함량에 미치는 실험적 효과
Immuno-stimulating Effects of BS-01 Made Using Extract of Acanthopanax Sessiliflorus on the Body Weight and Serum Lipid Level in Obesity-induced Mice
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hyperlipidemia has been treated as one of the most important etiological cause factor in 21th century. The cortex and root of Acanthopanax sessiliflorus (AR), a herbal medicine, have been used for several diseases including cardiovascular diseases in Oriental countries. Recently, we reported that AR has anti-hyperlipidemic action. BS-01 was made using extract from AR. For these reasons, we investigated the effects of BS-01 as anti-hyperlipidemic drug through measurement of body weights, cholesterol levels, total lipid, phospholipid in serum. In our results, mice induced by high fat diet elevated body weight level compared to naive group. And total lipid in serum was also elevated by induction of hyperlipidemia. In BS-01 group, body weight of mice was lowered significantly compared to that of control group. Oral administration of BS-01 decreased total cholesterol and triglyceride level back to that of naive mice. HDL and LDL cholesterol levels were not affected by BS-01. In addition, total lipid level, which elevated by induction of hyperlipidemia was also lowered by oral administration of BS-01. Finally, free fatty acid level was lowered in BS-01 group. These results demonstrate that BS-01 lowered body weight and titers involved in hyperlipdemia such as total cholesterol, triglyceride, free fatty acid and total lipid. In these results, we demonstrate that BS-01 has anti-hyperlipidemic action.
Abstract
Hyperlipidemia has been treated as one of the most important etiological cause factor in 21th century. The cortex and root of Acanthopanax sessiliflorus (AR), a herbal medicine, have been used for several diseases including cardiovascular diseases in Oriental countries. Recently, we reported that AR has anti-hyperlipidemic action. BS-01 was made using extract from AR. For these reasons, we investigated the effects of BS-01 as anti-hyperlipidemic drug through measurement of body weights, cholesterol levels, total lipid, phospholipid in serum. In our results, mice induced by high fat diet elevated body weight level compared to naive group. And total lipid in serum was also elevated by induction of hyperlipidemia. In BS-01 group, body weight of mice was lowered significantly compared to that of control group. Oral administration of BS-01 decreased total cholesterol and triglyceride level back to that of naive mice. HDL and LDL cholesterol levels were not affected by BS-01. In addition, total lipid level, which elevated by induction of hyperlipidemia was also lowered by oral administration of BS-01. Finally, free fatty acid level was lowered in BS-01 group. These results demonstrate that BS-01 lowered body weight and titers involved in hyperlipdemia such as total cholesterol, triglyceride, free fatty acid and total lipid. In these results, we demonstrate that BS-01 has anti-hyperlipidemic action.
참고문헌 (23)
- 식품의약품안전청, "대한약전(제9개정)", pp.954~ (2007), 서울, 식품의약품안전청
- 김형석, "五加皮의 形態에 관한 硏究", 대한본초학회지, 23(2), pp.41~49 (2008), 대한본초학회
- 孫星衍輯, "神農本草經", pp.39~ (1999), 北京, 科學技術文獻出版社
- 全國韓醫科大學 本草學敎授, "本草學", pp.283~284 (1999), 서울, 永林社
- 康秉秀, "方劑의 體系的 構成을 위한 臨床配合本草學", pp.644~645 (1996), 서울, 永林社
- Brekhman, I.I., "“Nauka" Publishers Leningrad through 1st International Symposium of gerontology Lugano", Lloydia, 32, pp.46~46 (1969)
- Park, M.S., "Using air temperature and sunshine duration data to select seed production site for Eleutherococcus Senticosus Max", Korean J. Crop Sci, 40, pp.444~450 (1995)
- Park, H.K., "Characteristics of embryo growth and dehiscence during the after-rip-ening period in Eleutherococcus senticosus", Korean J. Crop Sci, 42, pp.673~677 (1997)
- Tkhor, L.F., "Obshchest 1 spyt Prir", Otd Biol, 16, pp.73~77 (1967)
- 정종운, "가시五加皮藥鍼이 糖尿誘發抑制 및 腎臟保護活性에 미치는 영향", 대한침구의학회지, 20(3), pp.1~ (2003), 대한침구의학회
- 김호철, "Human Monocyte의 IL-8 생산억제에 미치는 류마토이드관절염 치료제로서의 오가피의 효과", 대한본초학회지, 10(1), pp.49~59 (1995)
- 정현우, "五加皮 抽出液이 免疫, 抗癌 및 肥滿에 미치는 실험적 효과", 동의생리병리학회지, 19(2), pp.389~397 (2005), 대한동의병리학회
- 정현우, "오가피 50 에탄올 추출물이 면역, 항암, 뇌혈류 및 혈압에 미치는 영향", 동의생리병리학회지, 19(5), pp.1213~1219 (2005), 대한동의병리학회
- 노영호, "오가피 Ethyl Alcohol 추출물이 뇌혈류역학 및 비만에 미치는 영향", pp.2006
- 김계엽, "방사선 조사 마우스에서 오가피의 면역활성 효과", 동의생리병리학회지, 20(3), pp.670~674 (2006), 대한동의병리학회
- 김영근, "오가피 에탄올 추출물이 마우스의 체중 및 혈청내 지질 함량에 미치는 효과", 동의생리병리학회지, 20(2), pp.352~357 (2006), 대한동의병리학회
- National Cholesterol Education Program, "Report of expert panel on detection, evaluation, and treatment expert panel on detection, evaluation, and treatment of high blood cholesterol in adults", Arch Int Med, 148, pp.36~69 (1998), National Heart, Lung and Blood Institute, NIH, Bethesda
- Tietz, N.W., "Clinical Guide to Laboratory tests(3rd Edition)", pp.334~611 (1995), Philadelphia, PA., WB Saunders Company
- 金井泉, "臨床檢査法提要(改訂 第3版)", pp.103~1386 (1993), 서울, 고문사
- 오가피를 통한 약용식물 산업화모델 개발에 관한 지역혁신인력양성사업 최종보고서, "전병관", 서울, 산업자원부, 4~5 (2007)
- 楊維傑編, "黃帝內經素問靈樞譯解(素問)", pp.243~ (1980), 서울, 成輔社
- 杜鎬京, "東醫腎系學", pp.1075~1083 (1991), 서울, 東洋醫學硏究院
- Kurt, J., lsselbacher, "Principles of Internal Medicine", pp.480~485 (1987)